Serial 98514227
Live / Applied — Statement of use — registration review complete (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 23 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98514227
- Mark type
- Design / logo
- Filed
- 23 Apr 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the treatment of oncologic diseases
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 31 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Sept 2025 — USE AMENDMENT FILED
- 30 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Apr 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 09 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE